Portable Sleep Monitors in Children With Autism Spectrum Disorder
PrSM
The Accuracy of Portable Sleep Monitoring for Children With Autism Spectrum Disorder
1 other identifier
observational
20
1 country
1
Brief Summary
The goal of this study is to evaluate the ability of a portable sleep monitor to detect obstructive sleep apnea in children with autism spectrum disorder (ASD). The main study objectives are to:
- 1.Evaluate the correlation between the obstructive apnea-hypopnea index (OAHI) on a portable sleep monitor and an in-laboratory polysomnogram (PSG);
- 2.Determine the sensitivity and specificity of a portable sleep monitor to diagnose obstructive sleep apnea (OSA);
- 3.Evaluate patient and family preferences for sleep testing.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Aug 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 12, 2025
CompletedFirst Submitted
Initial submission to the registry
September 17, 2025
CompletedFirst Posted
Study publicly available on registry
January 26, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
January 26, 2026
January 1, 2026
1.4 years
September 17, 2025
January 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Obstructive Apnea-Hypopnea Index (OAHI) measured from the portable sleep monitor and from the polysomnogram (PSG)
The OAHI measured from the portable sleep monitor will be compared to the OAHI measured from the PSG, the gold standard test for sleep-disordered breathing, to determine the ability of the portable sleep monitor to diagnose obstructive sleep apnea.
Baseline
Secondary Outcomes (21)
Patient and Family Preferences
0-3 months after the baseline PSG
Insomnia Questionnaire
+/- 1 week from baseline PSG sleep test
Chronotype Questionnaire
+/- 1 week from baseline PSG sleep test
Chronotype Questionnaire
+/- 1 week from baseline PSG sleep test
Chronotype Questionnaire
+/- 1 week from baseline PSG sleep test
- +16 more secondary outcomes
Study Arms (1)
Children with ASD testing a portable sleep monitor
Children aged 6-18 years old with autism spectrum disorder concurrently testing a portable sleep monitor (Nox T3s) during their first clinical polysomnogram. Children and their caregivers may also complete a qualitative interview about sleep testing preferences after their sleep test.
Interventions
Participants will test the Nox T3s portable sleep monitor concurrently during their in-hospital clinical polysomnogram.
Eligibility Criteria
Children who are undergoing a clinical PSG at British Columbia's Children's Hospital in Vancouver, Canada.
You may qualify if:
- Children between 6 to 18 years of age, AND;
- Children diagnosed with autism spectrum disorder, AND;
- Children who will be undergoing a polysomnogram (PSG) for the first time, AND;
- Caregiver willing to complete questionnaires about child's sleep and behavior
You may not qualify if:
- Children who are currently using respiratory therapy
- Children who have previously completed a PSG
- Caregiver unwilling to complete questionnaires about child's sleep and behavior
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Lena Xiaolead
Study Sites (1)
British Columbia Children's Hospital
Vancouver, British Columbia, V6H 3N1, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Clinical Assistant Professor
Study Record Dates
First Submitted
September 17, 2025
First Posted
January 26, 2026
Study Start
August 12, 2025
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
January 26, 2026
Record last verified: 2026-01